BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH & PROGRESSION

非黑色素瘤皮肤癌生长的生物学

基本信息

  • 批准号:
    2882427
  • 负责人:
  • 金额:
    $ 83.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-05-06 至 2001-07-31
  • 项目状态:
    已结题

项目摘要

The incidence of non-melanoma skin cancer (NMSC) is increasing rapidly, and further increases are expected. A small proportion of these basal and squamous cell carcinomas of the skin exhibit an aggressive phenotype, characterized by multiple recurrences, size more then 2 cm, invasion of muscle, cartilage, bone, or nerves, or lymph node metastasis. The State of Texas has a high incidence of skin cancer and an unusually high death rate from NMSC. Because of its geographic location and referral patterns, the University of Texas M. D. Anderson Cancer Center treats a large number of highly aggressive NMSC; in fact, nearly half of the approximately 100 new cases of skin cancer seen annually in the Department of Head and Neck Surgery exhibit aggressive behavior and are difficult to control by surgery and radiation. Progress toward reducing the incidence of and morbidity and mortality from NMSC requires a 3-pronged approach; Identification of the etiologic and genetic factors that contribute to skin cancer induction; determination of the host and tumor characteristics associated with skin cancer progressions; and development of new approaches for the treatment of highly aggressive NMSC. The specific aims of this Program are therefore, to (1) develop an understanding of the molecular events leading to skin cancer development; (2) ascertain athe role of UV radiation in the development of NMSC, including those with aggressive behavior, (3) assess the contribution of various mechanisms to progression of NMSC; (4) reduce morbidity and mortality and improve the quality of life of patients with aggressive skin cancer. These goals will be addressed by 16 Key Program Investigators in laboratory and clinical investigations on the role of p53 in UV carcinogenesis and immunosuppression (Project 1); regulation of apoptosis in skin cancer development (Project 2); DNA repair and chromosome instability in skin cancers (Project 3); and adjuvant biotherapy of aggressive skin cancers with 13-cis retinoic acid and interferon-alpha (Project 5). These studies will be coordinated and supported by cores devoted to collection of clinical, pathological, molecular, and epidemiological data and procurement, maintenance, processing, and distribution of clinical samples and biostatistical analysis and integration of laboratory and clinical data. These efforts will be supported by 16 collaborators/co-investigators and 8 Program Advisors. The Program Project will provide information on the etiology, biology, pathogenesis, and mechanisms of induction of NMSC and generate valuable clinical and epidemiological databases.
非黑色素瘤皮肤癌(NMSC)的发病率正在迅速增加

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARGARET L KRIPKE其他文献

MARGARET L KRIPKE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARGARET L KRIPKE', 18)}}的其他基金

54th Annual Syposium on Fundamental Cancer Research
第 54 届基础癌症研究年度研讨会
  • 批准号:
    6368844
  • 财政年份:
    2001
  • 资助金额:
    $ 83.57万
  • 项目类别:
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS
P53 在紫外线免疫抑制和致癌作用中的作用
  • 批准号:
    6643605
  • 财政年份:
    2001
  • 资助金额:
    $ 83.57万
  • 项目类别:
EXTRAMURAL RES FACILITIES CONSTR PROJECT
校外资源设施建设项目
  • 批准号:
    6419955
  • 财政年份:
    2001
  • 资助金额:
    $ 83.57万
  • 项目类别:
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS
P53 在紫外线免疫抑制和致癌作用中的作用
  • 批准号:
    6485989
  • 财政年份:
    2001
  • 资助金额:
    $ 83.57万
  • 项目类别:
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS
P53 在紫外线免疫抑制和致癌作用中的作用
  • 批准号:
    6311539
  • 财政年份:
    2000
  • 资助金额:
    $ 83.57万
  • 项目类别:
53RD ANNUAL SYMPOSIUM ON FUNDAMENTAL CANCER RESEARCH
第 53 届基础癌症研究年度研讨会
  • 批准号:
    6191804
  • 财政年份:
    2000
  • 资助金额:
    $ 83.57万
  • 项目类别:
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS
P53 在紫外线免疫抑制和致癌作用中的作用
  • 批准号:
    6203325
  • 财政年份:
    1999
  • 资助金额:
    $ 83.57万
  • 项目类别:
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS
P53 在紫外线免疫抑制和致癌作用中的作用
  • 批准号:
    6103104
  • 财政年份:
    1998
  • 资助金额:
    $ 83.57万
  • 项目类别:
IMMUNOLOGIC CONTROL OF MELANOMA PULMONARY METASTASIS
黑色素瘤肺转移的免疫控制
  • 批准号:
    2011640
  • 财政年份:
    1997
  • 资助金额:
    $ 83.57万
  • 项目类别:
ROLE OF P53 IN UV IMMUNE SUPPRESSION AND CARCINOGENESIS
P53 在紫外线免疫抑制和致癌作用中的作用
  • 批准号:
    6237593
  • 财政年份:
    1997
  • 资助金额:
    $ 83.57万
  • 项目类别:

相似海外基金

'What then do I love, when I love my God?': Divine personae and the human subject in the devotional culture of late fourteenth-century Yorkshire.
“当我爱我的上帝时,我爱什么呢?”:十四世纪末约克郡虔诚文化中的神圣人物和人类主体。
  • 批准号:
    2742225
  • 财政年份:
    2022
  • 资助金额:
    $ 83.57万
  • 项目类别:
    Studentship
Human Subject Core
人类主体核心
  • 批准号:
    10574519
  • 财政年份:
    2021
  • 资助金额:
    $ 83.57万
  • 项目类别:
Human Subject Core
人类主体核心
  • 批准号:
    10596985
  • 财政年份:
    2021
  • 资助金额:
    $ 83.57万
  • 项目类别:
Human Subject Core
人类主体核心
  • 批准号:
    10360441
  • 财政年份:
    2021
  • 资助金额:
    $ 83.57万
  • 项目类别:
Study for the development of ethical fuidelines and review methodology for non-medical human subject research at Universities
大学非医学人类课题研究的道德准则发展和审查方法研究
  • 批准号:
    21K13658
  • 财政年份:
    2021
  • 资助金额:
    $ 83.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Human Subject Core
人类主体核心
  • 批准号:
    10379916
  • 财政年份:
    2021
  • 资助金额:
    $ 83.57万
  • 项目类别:
Human Subject Core
人类主体核心
  • 批准号:
    10091061
  • 财政年份:
    2021
  • 资助金额:
    $ 83.57万
  • 项目类别:
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus: Human Subject Testing
拇强直患者的关节运动特征和恢复:人体测试
  • 批准号:
    10710384
  • 财政年份:
    2020
  • 资助金额:
    $ 83.57万
  • 项目类别:
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus: Human Subject Testing
拇强直患者的关节运动特征和恢复:人体测试
  • 批准号:
    10262929
  • 财政年份:
    2020
  • 资助金额:
    $ 83.57万
  • 项目类别:
Understanding Gender Bias in Human Subject Sampling in HCI Research
了解人机交互研究中人类受试者抽样中的性别偏见
  • 批准号:
    542746-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 83.57万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了